This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
SA
Not CommonVerified
Sweet Annie
Artemisia annua
Malaria and intermittent fevers in TCM for 2000 years
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Artemisia annua, also known as sweet wormwood or sweet annie, is a member of the Asteraceae family used primarily for its potent antimalarial properties [PMID:16612385, PMID:40061692].
Background
Artemisia annua L. is a species of wormwood native to temperate Asia and naturalized worldwide [PMID:40061692]. It is a traditional Chinese herbal medicine used for over 2,000 years [PMID:19818170, PMID:40840727].
Traditional uses
Traditionally used in Chinese medicine to treat malaria, bacterial infections, inflammation, various cancers, parasites, intermittent fevers, bone steaming, heat/fever from exhaustion, tuberculosis, lice, wounds, scabies, and dysentery [PMID:40840727, PMID:32758647]. In Egyptian folk medicine, aerial parts are used for respiratory, digestive, and sexual dysfunctions [PMID:37127141].
Active compounds
The plant is rich in secondary metabolites including sesquiterpene lactones (notably artemisinin and its derivatives), monoterpenes, phenolic compounds, polyphenols, and quercetin [PMID:16612385, PMID:32679734, PMID:40840727]. Specific volatile compounds include artemisia ketone, trans-caryophyllene, 1,8-cineole, and camphor [PMID:35170197].
Mechanism of action
Artemisinin exhibits anti-angiogenic and growth inhibition effects, and induces apoptosis via its inherent endo-peroxidase activity [PMID:30697504]. In cancer, it modulates cell signaling pathways, induces autophagy, and impacts oxidative stress and DNA damage [PMID:39739138]. Against SARS-CoV-2, compounds like scopoletin and artemisinic acid interact with 3CLpro and Spike proteins to interfere with viral insertion and replication [PMID:37832410].
Clinical evidence
Evidence CMalaria
Artemisinin and its derivatives are highly effective against multi-drug-resistant Plasmodium spp. and are the basis for recommended artemisinin-based combination therapies (ACTs) [PMID:16612385, PMID:28837410].
Evidence CCancer
Animal experiments show artemisinin-type drugs can prevent tumor development and metastasis, but there is no conclusive proof from human trials that these benefits extend to cancer patients [PMID:40061692, PMID:29746932].
Evidence DTesticular Dysfunction (Obese Rats)
Crude leaf extract of Artemisia annua attenuated high-fat diet-induced testicular dysfunctions and improved spermatogenesis in rats [PMID:37127141].
Safety & adverse effects
Experiences with malaria treatment indicate that artemisinin-based medicines are generally well-tolerated [PMID:40061692].
Evidence summary
Strong evidence exists for the antimalarial efficacy of artemisinin (Review/C). Evidence for anticancer and other biological activities is currently based on in vitro, animal models, or reviews (C/D), with a noted lack of conclusive human clinical trial data for cancer.
PubMed sources
1.PMID: 16612385 (2006) — Production of the antimalarial drug precursor artemisinic acid in engineered yeast. · Nature
2.PMID: 35280785 (2022) — Editorial: Anticancer Potential of Artemisia annua. · Frontiers in oncology
3.PMID: 31983619 (2020) — Genetic Control of Glandular Trichome Development. · Trends in plant science
4.PMID: 18977499 (2008) — Making artemisinin. · Phytochemistry
5.PMID: 40840727 (2025) — The role and mechanism of Artemisia annua L. in cancer treatment. · Journal of ethnopharmacology
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
18.PMID: 40061692 (2024) — Unlocking the Therapeutic Benefits of Artemisia Annua: A Comprehensive Overview of its Medicinal Properties. · Journal of pharmacy & bioallied sciences
19.PMID: 30697504 (2018) — Artemisinin: A Promising Adjunct for Cancer Therapy. · Cureus
21.PMID: 35144142 (2022) — Control of resource allocation between primary and specialized metabolism in glandular trichomes. · Current opinion in plant biology
22.PMID: 33614607 (2020) — High-Level Patchoulol Biosynthesis in Artemisia annua L. · Frontiers in bioengineering and biotechnology
23.PMID: 31741871 (2019) — Potential applications of artemisinins in ocular diseases. · International journal of ophthalmology
24.PMID: 37233654 (2023) — Secondary Metabolites Isolated from Artemisia afra and Artemisia annua and Their Anti-Malarial, Anti-Inflammatory and Immunomodulating Properties-Pharmacokinetics and Pharmacodynamics: A Review. · Metabolites
25.PMID: 35170197 (2022) — Comparative Study of the Essential Oil and Hydrosol Composition of Sweet Wormwood (Artemisia annua L.) from Serbia. · Chemistry & biodiversity
26.PMID: 29187859 (2017) — A Review of Biotechnological Artemisinin Production in Plants. · Frontiers in plant science
27.PMID: 39739138 (2024) — Artemisinin's molecular symphony: illuminating pathways for cancer therapy. · Molecular biology reports
28.PMID: 35369084 (2022) — Optimization of the Artemisia Polysaccharide Fermentation Process by Aspergillus niger. · Frontiers in nutrition
29.PMID: 35566390 (2022) — Biotechnological Approaches for Production of Artemisinin, an Anti-Malarial Drug from Artemisia annua L. · Molecules (Basel, Switzerland)
30.PMID: 37832410 (2023) — Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie